Endobronchial ultrasound–guided transbronchial needle aspiration for non–small cell lung cancer staging
CM Kinsey, DA Arenberg - … journal of respiratory and critical care …, 2014 - atsjournals.org
Real-time endobronchial ultrasound–guided transbronchial needle aspiration (EBUS-TBNA)
is an established technique for invasive mediastinal staging of non–small cell lung cancer …
is an established technique for invasive mediastinal staging of non–small cell lung cancer …
[HTML][HTML] Ultrasound techniques in the evaluation of the mediastinum, part 2: mediastinal lymph node anatomy and diagnostic reach of ultrasound techniques, clinical …
C Jenssen, JT Annema, P Clementsen… - Journal of thoracic …, 2015 - ncbi.nlm.nih.gov
Ultrasound imaging has gained importance in pulmonary medicine over the last decades
including conventional transcutaneous ultrasound (TUS), endoscopic ultrasound (EUS), and …
including conventional transcutaneous ultrasound (TUS), endoscopic ultrasound (EUS), and …
CT texture analysis can help differentiate between malignant and benign lymph nodes in the mediastinum in patients suspected for lung cancer
MB Andersen, SW Harders, B Ganeshan… - Acta …, 2016 - journals.sagepub.com
Background In patients with non-small-cell lung carcinoma NSCLC the lymph node staging
in the mediastinum is important due to impact on management and prognosis. Computed …
in the mediastinum is important due to impact on management and prognosis. Computed …
Optimizing endobronchial ultrasound for molecular analysis. How many passes are needed?
Background: The current oncologic management of non–small cell lung cancer (NSCLC)
requires pathologic differentiation between adenocarcinoma and squamous cell carcinoma …
requires pathologic differentiation between adenocarcinoma and squamous cell carcinoma …
Mediastinal lymphadenopathy: a practical approach
H Iyer, A Anand, PB Sryma, K Gupta… - Expert Review of …, 2021 - Taylor & Francis
Introduction: Mediastinal lymphadenopathy is secondary to various benign and malignant
etiologies. There is a variation in the underlying cause in different demographic settings. The …
etiologies. There is a variation in the underlying cause in different demographic settings. The …
A single EBUS-TBNA procedure can support a large panel of immunohistochemical stains, specific diagnostic subtyping, and multiple gene analyses in the majority of …
Targeted therapies for pulmonary adenocarcinoma (ACA) necessitate specific subtyping
and molecular testing of non–small cell lung carcinomas (NSCLC). However, endobronchial …
and molecular testing of non–small cell lung carcinomas (NSCLC). However, endobronchial …
The importance of a satisfactory biopsy for the diagnosis of lung cancer in the era of personalized treatment
LM Ofiara, A Navasakulpong, N Ezer, AV Gonzalez - Current Oncology, 2012 - mdpi.com
Advances in molecular biology are improving the understanding of lung cancer and
changing the approach to treatment. A satisfactory biopsy that allows for histologic …
changing the approach to treatment. A satisfactory biopsy that allows for histologic …
The diagnostic value of MR imaging in determining the lymph node status of patients with non–small cell lung Cancer: a meta-analysis
J Peerlings, EGC Troost, PJ Nelemans, DCP Cobben… - Radiology, 2016 - pubs.rsna.org
Purpose To summarize existing evidence of thoracic magnetic resonance (MR) imaging in
determining the nodal status of non–small cell lung cancer (NSCLC) with the aim of …
determining the nodal status of non–small cell lung cancer (NSCLC) with the aim of …
Optimizing tissue sampling for the diagnosis, subtyping, and molecular analysis of lung cancer
LM Ofiara, A Navasakulpong, S Beaudoin… - Frontiers in …, 2014 - frontiersin.org
Lung cancer has entered the era of personalized therapy with histologic subclassification
and the presence of molecular biomarkers becoming increasingly important in therapeutic …
and the presence of molecular biomarkers becoming increasingly important in therapeutic …
10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45 Gy (1.5 …
WEE Eberhardt, TC Gauler, C LePechoux, G Stamatis… - Lung cancer, 2013 - Elsevier
Background Induction chemoradiotherapy plus surgery remains an option to study in IIIA
(N2) and selected IIIB NSCLC. Here we report ten-year long-term survival of a prospective …
(N2) and selected IIIB NSCLC. Here we report ten-year long-term survival of a prospective …